new distribution agreements, page-12

Yes - there's a very strong story in that Ajl.

Why does a large company with such a successful track record turn to SBN to produce the membranes? Why not do it themselves. Simply because SBN has the superior measurement technology and Bioscreens knows that. As does Avitar, another large US company, that SBN is currently suing for patent infringement. We should here more about that soon.

SBN is doing the right thing in linking its superior technology to the marketing and distribution clout of larger established companies.